Tresuvi 1 mg/ ml Norveġja - Norveġiż - Statens legemiddelverk

tresuvi 1 mg/ ml

amomed pharma gmbh - treprostinilnatrium - infusjonsvæske, oppløsning - 1 mg/ ml

Tresuvi 2.5 mg/ ml Norveġja - Norveġiż - Statens legemiddelverk

tresuvi 2.5 mg/ ml

amomed pharma gmbh - treprostinilnatrium - infusjonsvæske, oppløsning - 2.5 mg/ ml

Tresuvi 5 mg/ ml Norveġja - Norveġiż - Statens legemiddelverk

tresuvi 5 mg/ ml

amomed pharma gmbh - treprostinilnatrium - infusjonsvæske, oppløsning - 5 mg/ ml

Zeposia Unjoni Ewropea - Norveġiż - EMA (European Medicines Agency)

zeposia

bristol-myers squibb pharma eeig - ozanimod hydrochloride - multiple sclerosis, relapsing-remitting; colitis, ulcerative - immunsuppressive - multiple sclerosiszeposia is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (rrms) with active disease as defined by clinical or imaging features. ulcerative colitiszeposia is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (uc) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biologic agent.

DERMOCOL GEL NEW Norveġja - Norveġiż - Ecolab

dermocol gel new

ecolab deutschland gmbh -

Kapruvia Unjoni Ewropea - Norveġiż - EMA (European Medicines Agency)

kapruvia

vifor fresenius medical care renal pharma france - difelikefalin - pruritus - alle andre terapeutiske produkter - kapruvia is indicated for the treatment of moderate-to-severe pruritus associated with chronic kidney disease in adult patients on haemodialysis (see section 5.

Abiraterone Qilu 500 mg Norveġja - Norveġiż - Statens legemiddelverk

abiraterone qilu 500 mg

qilu pharma spain s.l. - abirateronacetat - tablett, filmdrasjert - 500 mg

Camzyos Unjoni Ewropea - Norveġiż - EMA (European Medicines Agency)

camzyos

bristol-myers squibb pharma eeig - mavacamten - cardiomyopathy, hypertrophic - andre hjertepreparater - treatment of symptomatic obstructive hypertrophic cardiomyopathy.

Fingolimod Tillomed 0.5 mg Norveġja - Norveġiż - Statens legemiddelverk

fingolimod tillomed 0.5 mg

tillomed pharma gmbh - schönefeld - fingolimodhydroklorid - kapsel, hard - 0.5 mg

Abiraterone Accord Unjoni Ewropea - Norveġiż - EMA (European Medicines Agency)

abiraterone accord

accord healthcare s.l.u. - abirateronacetat - prostata neoplasmer - endokrin terapi - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.